Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Experimental Hematology ; (6): 902-906, 2023.
Artigo em Chinês | WPRIM | ID: wpr-982148

RESUMO

Obesity-associated protein (FTO) is an important m6A demethylase that regulates RNA methylation modification and can promote the proliferation of acute myeloid leukemia(AML) cells. FTO regulates the methylation level of AML through multiple cellular signaling pathways such as FTO/RARA/ASB2, FTO/m6A/CEBPA, and PDGFRB/ERK, and participates in the occurrence, development, treatment and prognosis of AML. At present, studies have found that a variety of inhibitors targeting FTO have shown good anti-leukemia effects, and the study of FTO will provide new ideas for the treatment of AML. This review focus on the mechanism of action of FTO in AML and the research progress of FTO inhibitors in AML.


Assuntos
Humanos , Metilação , Leucemia Mieloide Aguda/genética , Prognóstico , Dioxigenase FTO Dependente de alfa-Cetoglutarato/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA